EIF4G1 and non-small cell lung carcinoma: The solid evidence has been provided that EIF4G1 inhibitors (eg 4EGI‐1 and 4E1RCat) display effective inhibition of NSCLC cell lines growth and tumorigenesis in vitro and in vivo.